Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian K Link

Showing results (61-70 of 231) with videos related to

Pageof 24
Sort By:
Blood|July 20, 2011
Rituximab infusion induces NK activation in lymphoma patients with the high-affinity CD16 polymorphismSuresh Veeramani, Siao-Yi Wang, Christopher Dahle, et al.
Journal of Cancer Survivorship : Research and Practice|January 4, 2020
Compliance with cancer screening and influenza vaccination guidelines in non-Hodgkin lymphoma survivorsPriyanka A Pophali, Melissa C Larson, Cristine Allmer, et al.
Cancer|June 28, 2017
Incidence of hematologic malignancy and cause-specific mortality in the Women's Health Initiative randomized controlled trial of calcium and vitamin D supplementationEric M Ammann, Matthew T Drake, Bjarni Haraldsson, et al.
British Journal of Haematology|April 4, 2018
Second-line and subsequent therapy and outcomes for follicular lymphoma in the United States: data from the observational National LymphoCare StudyBrian K Link, Bann-Mo Day, Xiaolei Zhou, et al.
Nuclear Medicine Communications|July 22, 2004
99mTc-depreotide tumour uptake in patients with non-Hodgkin's lymphomaDavid L Bushnell, Yusuf Menda, Mark T Madsen, et al.
Leukemia & Lymphoma|February 10, 2010
18-Fluoro-deoxyglucose positron emission tomography report interpretation as predictor of outcome in diffuse large B-cell lymphoma including analysis of 'indeterminate' reportsAlexandra Thomas, Roger D Gingrich, Brian J Smith, et al.
Blood|June 25, 2015
Outcomes of transformed follicular lymphoma in the modern era: a report from the National LymphoCare Study (NLCS)Nina D Wagner-Johnston, Brian K Link, Michelle Byrtek, et al.
American Journal of Hematology|April 29, 2016
Disease, treatment, and outcome differences between men and women with follicular lymphoma in the United StatesChadi Nabhan, Xiaolei Zhou, Bann-Mo Day, et al.
Pharmacotherapy|May 19, 2005
Effect of clinical characteristics on neutropenia-related inpatient costs among newly diagnosed non-Hodgkin's lymphoma cases during first-course chemotherapyElizabeth A Chrischilles, Donald G Klepser, John M Brooks, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2012
Effectiveness of first-line management strategies for stage I follicular lymphoma: analysis of the National LymphoCare StudyJonathan W Friedberg, Michelle Byrtek, Brian K Link, et al.
Pageof 24

Showing results (61-70 of 231) with videos related to

Sort By:
Pageof 24
Blood|July 20, 2011
Rituximab infusion induces NK activation in lymphoma patients with the high-affinity CD16 polymorphismSuresh Veeramani, Siao-Yi Wang, Christopher Dahle, et al.
Journal of Cancer Survivorship : Research and Practice|January 4, 2020
Compliance with cancer screening and influenza vaccination guidelines in non-Hodgkin lymphoma survivorsPriyanka A Pophali, Melissa C Larson, Cristine Allmer, et al.
Cancer|June 28, 2017
Incidence of hematologic malignancy and cause-specific mortality in the Women's Health Initiative randomized controlled trial of calcium and vitamin D supplementationEric M Ammann, Matthew T Drake, Bjarni Haraldsson, et al.
British Journal of Haematology|April 4, 2018
Second-line and subsequent therapy and outcomes for follicular lymphoma in the United States: data from the observational National LymphoCare StudyBrian K Link, Bann-Mo Day, Xiaolei Zhou, et al.
Nuclear Medicine Communications|July 22, 2004
99mTc-depreotide tumour uptake in patients with non-Hodgkin's lymphomaDavid L Bushnell, Yusuf Menda, Mark T Madsen, et al.
Leukemia & Lymphoma|February 10, 2010
18-Fluoro-deoxyglucose positron emission tomography report interpretation as predictor of outcome in diffuse large B-cell lymphoma including analysis of 'indeterminate' reportsAlexandra Thomas, Roger D Gingrich, Brian J Smith, et al.
Blood|June 25, 2015
Outcomes of transformed follicular lymphoma in the modern era: a report from the National LymphoCare Study (NLCS)Nina D Wagner-Johnston, Brian K Link, Michelle Byrtek, et al.
American Journal of Hematology|April 29, 2016
Disease, treatment, and outcome differences between men and women with follicular lymphoma in the United StatesChadi Nabhan, Xiaolei Zhou, Bann-Mo Day, et al.
Pharmacotherapy|May 19, 2005
Effect of clinical characteristics on neutropenia-related inpatient costs among newly diagnosed non-Hodgkin's lymphoma cases during first-course chemotherapyElizabeth A Chrischilles, Donald G Klepser, John M Brooks, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2012
Effectiveness of first-line management strategies for stage I follicular lymphoma: analysis of the National LymphoCare StudyJonathan W Friedberg, Michelle Byrtek, Brian K Link, et al.
Pageof 24